Navigation Links
Frost & Sullivan Hosts Analyst Briefing: An Outlook of Azerbaijan and Iran Healthcare Markets
Date:7/25/2013

LONDON, July 25, 2013 /PRNewswire/ -- WHEN: 4pm BST on Thursday 1st August 2013 LOCATION: Online, with free registrationPRESENTERS: Healthcare Research Analysts Hilal Cura and Uldouz BerenjforoushWith their growing GDP and government's focus on reforms and development, Azerbaijan and Iran healthcare markets open up their doors to global companies and private investors, offering new opportunities across all segments, from the pharmaceutical field to the medical devices industry, as well as medical tourism.

Attend this webinar to:

  • Learn about the growth of Azerbaijan and Iran healthcare market
  • Identify the drivers and restraints
  • Discover trends across all market segments
  • This briefing will benefit global companies and private investors in the pharmaceutical, medical devices and medical services fields, by discussing current and emerging trends and providing forward-looking projections.

    Supporting Quotes"A young but rapidly growing oil-rich Azerbaijan presents itself as an untouched ground for investment. With its ever increasing GDP, we see healthcare expenditure following the same path as well. Azerbaijan has also gone through extensive reforms to ensure growth and development in its healthcare industry," notes Frost & Sullivan Research Analyst Hilal Cura.

    "A natural resource rich nation of over 75 million people - more than 50% of which under the age of 35 - Iran enjoys an enormous amount of wealth coming in from its oil & gas reservoirs. Its GDP is estimated to grow at an average of 2.4% over the next 10 years, offering interesting opportunities across all industries. Iran's healthcare industry was worth 26.44bn USD in 2011 and has grown to 28.13bn USD in 2012, up 6.4%," notes Frost & Sullivan Healthcare Research Analyst Uldouz Berenjforoush.

    Supporting ResourcesFor more information about Frost & Sullivan's Healthcare practice, please visit:

    http://www.frost.com/prod/servlet/svcg.pag/HC00

    Registration

  • To attend the briefing, email anna.zanchi@frost.com your full name, job title, company name, company telephone number, company email address and website, city, state and country.
  • Receive a recorded version of the briefing anytime by submitting the aforementioned contact details.
  • About Frost & SullivanFrost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

    Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
  • For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

    Contact Us:
    Start the discussion

    Join Us:
    Join our community

    Subscribe:
    Newsletter on "the next big thing"

    Register:
    Gain access to visionary innovation

    Contact
    Anna Zanchi
    Corporate Communications – Europe
    P: 0039 02 46514819
    E: anna.zanchi@frost.com
    http://www.frost.com


    '/>"/>
    SOURCE Frost & Sullivan
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
    2. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
    3. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
    4. Frost & Sullivan Research Preview: Top 20 Telehealth Markets
    5. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan
    6. Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market
    7. MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
    8. Frost & Sullivan: Developing Integration Capabilities Presents a Real Opportunity for Vendors in the European CIS Market
    9. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
    10. Electronic Medical Records Progress from an Enterprise-Centric Solution to a Customer-Specific Application, Finds Frost & Sullivan
    11. Frost & Sullivan to Host Complimentary Web Conference: Concerns and Solutions for the Anaesthesia Equipment and Associated Peripherals Market
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical ... the company with their  2017 New Product Innovation Award ... on extensive primary and secondary medical device market research by ... through its first-to-market OTC, drug-free pain relief product, the AVACEN ... approach to treating fibromyalgia widespread pain. ...
    (Date:10/11/2017)...  Caris Life Sciences ® , a leading innovator ... precision medicine, today announced that St. Jude Medical Center,s ... (POA) as its 17 th member. Through participation ... Cancer Institute will help develop standards of care and ... making cancer treatment more precise and effective. ...
    (Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
    Breaking Medicine Technology:
    (Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading ... Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly ... CBD form that can be easily incorporated into liquid products, while reducing costs to ...
    (Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
    (Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
    (Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
    (Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
    Breaking Medicine News(10 mins):